ESC 365 - The new ILEP 2024 guidelines on the dyslipidemia therapy of very high and extremely high-risk cardiovascular disease patients: is upfront lipid-lowering therapy (LLT) the best solution?

Open Access

The new ILEP 2024 guidelines on the dyslipidemia therapy of very high and extremely high-risk cardiovascular disease patients: is upfront lipid-lowering therapy (LLT) the best solution?

Session: Comprehensive personalised approach to lipid disorders in 2024

Topic: Risk Factors and Prevention

Speaker: Professor M. Banach (Lodz, PL)

Event: ACNAP Congress 2024

Congress Presentation

Add to my library

About the speaker

Professor Maciej Banach

Medical University of Lodz, Lodz (Poland)

8 presentations

2 followers

3 more presentations in this session

How to optimally stratify the cardiovascular risk: what awaits us in relation to new available biomarkers?

Speaker: Professor Z. Fras (Ljubljana, SI)

The lower, the better for longer? the earlier the better? We can do this, but mostly we miss the opportunity

Speaker: Doctor P. Sabouret (Paris, FR)

Multilevel education as a way to increase adherence and improve therapy: how to do it

Speaker: Professor D. Gaita (Timisoara, RO)

Access the full session

Comprehensive personalised approach to lipid disorders in 2024

Speakers: Professor M. Banach, Professor Z. Fras, Doctor P. Sabouret, Professor D. Gaita

About the event

ACNAP Congress 2024

14 June - 15 June 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources